Complianceonline
Harshit
Hi,
Our website is www.complianceonline.com - one of the largest training portals in the USA and Europe for the past 10 years. We organize industry expert-driven training seminars / webinars for all industries.
Our Trainings are meant for :
All Corporate Decision makers (CEOs, CTOs, CMOs, All purchase managers, all department heads )
Risk management officers
Process engineers
Quality officers/assurance managers
Documentation/Records department officials
Financial officers and all related to risk and compliance in companies.
HR Managers
OSHA compliance officers /managers.
Business Development Professionals
Consultants
Offerings
Showing 1051-1075 of 1075 results
-
Upon completion of this session, attendees will understand cGMP and ICH validation requirements for analytical procedures and learn key factors that would affect validation process of analytical procedures. It will help scientists develop process for evaluation method validation, review changes, and determine when re-validation would need to take place. It will discuss observations and infractions related to method validation.
-
Areas Covered in the Webinar:
Concept of quality management system
All clauses in ISO 13485
Auditable clauses of ISO 13485
All parts of the FDA’s QSR
Who is responsible for complying with QSR
Differences between ISO 13485 and QSR
Role of management in quality
Exclusions from specific parts of the regulation or standard
Internal audit requirement
Who Will Benefit:
Medical device manufacturers
R&D teams for medical devices
Personnel involved in the packaging of medical devices and packaging engineers
Inventory control personnel in a medical device company
Quality personnel and quality engineers
Suppliers to medical device companies
Biomedical engineers
Manufacturing engineers
-
Areas Covered in the Webinar:
Definition of Financial Statement Fraud
Common Reasons for Financial Statement Fraud
Red Flags to Look for in Fraudulent Financial Statements
Basic Understanding of How Financial Statement Fraud is Committed
Analysis used to Detect Financial Statement Fraud
Other Methods of Vetting Financial Statements
Who Will Benefit:
Investors and their brokers, money managers, etc.
Lending officers
Credit and collection department personnel
M&A personnel
Financial institution compliance personnel
Banking compliance personnel
Internal auditors
External auditors
-
Areas Covered in the Webinar:
Verification & validation types.
Definitions.
Design control.
Process control.
Application.
Consequences of poor verification & validation.
Why verification & validation makes good business sense?
-
Learning Objectives:
Gain a practical understanding of the Schedule M-3 reporting and disclosure requirements.
Learn about changes to Schedule M-3 reporting requirements for 2014 tax year.
Learn about how to complete Schedule M-3 for a parent-subsidiary consolidated group.
Understand how to identify and substantiate uncertain tax positions on the Schedule UTP.
Learn why it is important to “get the numbers right” when completing Schedules M-3 and UTP.
-
Learning Objectives:
To educate attendees on the vital reasons for risk management and the key role it plays in the product life cycle
To demonstrate the requirements of ISO 14971, how they reflect FDA concerns
To clarify how risk management impacts international standards, such as IEC 60601, and how to conform to risk management requirements
To provide practical application experience and skills in the process and tools of risk management, enabling attendees to be effective risk managers
To teach how to establish a quantitative risk management system and one that complies with EN/ISO 14971:2012
To provide attendees with the Dos and Don'ts for an effective and efficient risk management system.
-
Learning Objectives:
Learn the technical details and rationale for selecting and analyzing well designed statistically based experiments.
Develop the confidence to design and execute experiments that maximizes information in your day-to-day activities.
Participate in discussions with other course attendees to increase your confidence and proficiency in statistical hypothesis testing.
Determine the most robust settings in your process to minimize the different sources of variability.
-
The vital role that financial intermediation plays in facilitating and promoting national and global economic activity by providing the means for making and receiving payments, for borrowing and lending, for effecting transactions, for insuring risks, and for raising capital and promoting investment
The increasing complexity and operational risk across financial systems.
The concentration of clearing and settlement processes in most financial systems.
Deepening interdependencies among financial industry participants within and across jurisdictions.
The recurring pattern of natural disasters or extreme weather conditions.
The possibility of terrorist or other malicious attacks targeted, directly or indirectly, at the infrastructure of the financial system.
A strong interest in maintaining public confidence in financial systems.
The objectives of this course is to provide professionals in the banking and financial sector with a sound foundation in the area of business.
-
The FDA inspection is one of the critical measures of your quality system and your organization as a whole. Since a perfect quality system is usually not implemented, the preparation for and management of an FDA inspection is critically important. A well-established quality system provides a solid foundation for passing FDA inspections; however, if you don’t proactively examine your quality system from the perspective of a FDA inspector, you can still have difficulties.
Note:
Use coupon code 232082 and get 10% off on registration.
-
Regulatory frameworks surrounding anti-money laundering
Objectives of an effective AML compliance program
Risk assessing your institution
Developing robust internal controls
Training for appropriate personnel
Expectations and duties of the appointed compliance officer
Effective audit program to ensure adequacy of your AML compliance program.
-
Learn how to conduct a risk assessment
Be able to design internal controls
Be able to evaluate and assess internal controls
Know what are key preventive and detective controls
Learn how good internal controls can reduce audit costs.
-
You will be able to answer the following questions with this course without saying, “I don’t know?”
What are the FDA’s import legal requirements and policy?
How do you deal with the FDA and the U.S. Customs and Border Patrol procedures?
What happens when your product is detained?
What happens if a foreign manufacturer is in trouble with the FDA?
How do you inter-act with the FDA to work out problems?
Why are import and export rules different or does it even matter?
Seminar Instructor Casper Uldriks is an "Ex-FDA Official" who has spent 32 years in FDA and his engagements focus on advertising and promotion, recalls, corrections and removals and enforcement. He currently trains FDA personnel and counsels clients on wide range of topics, including: FDA inspections; import operations; advertising and promotion; corrective and preventive actions; medical device reporting and corporate reorganization to improve conformance to the FDA’s requirements.
-
Learning Objectives:
By using the RBIA approach, the organization’s internal audit should be able to conclude that:
Management has identified, assessed and responded to risks within and beyond the organization’s risk appetite
That the responses to risks are effective but not excessive in managing inherent risks within this risk appetite
Where residual risks are not in line with the risk appetite, action is being taken to remedy this
Risk management processes, including the effectiveness of responses and the completion of actions, are being monitored by management to ensure they continue to operate effectively
Risks, responses and actions are being properly classified and reported.
-
Learning Objectives
Upon completing this course participants will understand:
Difference between a traditional, abbreviated and special 510(k) and when to submit each type of 510(k)
When to file for a new device, a change in the intended use or a change in the technology of a cleared device
What is contained in a traditional, abbreviated and special 510(k) submission package
The submission package, user fees and making an eCopy
What is substantial equivalence and what’s required to show substantial equivalence
What’s required on the labeling and IFU
Which performance tests should be conducted and how to present the data to the FDA
The requirements for a risk management plan and report
Understand the FDA’s Refuse to Accept Policy
What is required in a submission for software controlled devices
How and when to use third party reviews
When clinical data may be required.
-
Recently, a series of headline-grabbing operational risk incidents at banks, other financial institutions and even regulators have again brought the issue of operational risk management to the forefront of the agendas of CEOs, CROs, risk managers and internal and external auditors alike. These incidents are wide ranging and flow from bank ATM collapses, bank operating system failures, regulatory settlements in the ongoing US sub-prime mortgage saga, rogue traders and the connected risk managers who either missed or were willfully blind to all the warning signs.
Key objectives and learning outcomes
The aim of the course is to provide:
Illustrate risk in all its facets
What the Basel Accords say about operational risk and its mitigation
Listing operational risk techniques for assessing, managing and mitigating operational risk
Note:
Use coupon code NB5SQH8N and get 10% off on registration.
-
Understand FDA rules and policies regarding manufacturing and labeling of low risk OTC drugs not covered by approved New Drug Applications.
Learn the definitions of drug, cosmetic, dietary supplement.
Understand how labeling other than labels and advertising can define a product and cause it to be misbranded or considered a new drug.
Differentiate cosmetic “puffery" claims from claims that FDA would likely consider drug claims.
Understand the differences between allopathic (conventional) drugs and homeopathic drugs.
Recognize ways to manufacture low health risk products at minimum cost, yet still meet the intent and basic requirements of GMP regulations.
Learn how to minimize the regulatory risk of a Warning Letter or other FDA action.
-
With the recent implementation of new HIPAA regulations in the HIPAA Omnibus Update of 2013, healthcare organizations are reviewing their compliance and making sure they have the proper policies, procedures, and forms in place. HIPAA Privacy Officers have been renewing their compliance activities and reviewing their documentation to make sure they can meet the challenges of the new rules and avoid breaches and penalties for compliance violations.
Who will Benefit
This seminar will provide valuable assistance to all personnel in medical offices, practice groups, hospitals, academic medical centers, insurers, business associates (shredding, data storage, systems vendors, billing services, etc.). The following personnel will find this session valuable:
Compliance director
CEO
COO
CFO
Privacy Officer
Security Officer
Information Systems Manager
HIPAA Officer
Note:
Use coupon code NB5SQH8N and get 10% off on registration.
-
Understand the SEC disclosure requirements based on new information and the 2013 filings
Apprehend key definitions and applicability
Be able to clearly delineate between RCOI and due diligence
Identify weaknesses in supplier data and ways to improve its reliability and credibility
Understand various CMR approaches and implications
Identify cost savings opportunities related to the IPSA
Recognize where they stand in relation to peer companies based on 2013 filings.
-
Understand the importance of food and nutritional supplement GMPs in protecting the public
See the impact of poor GMP performance
Become a HACCP subject matter expert
Understand the impact on product quality and on business success
Know how facility design affects product quality
Understand the dos and don’ts of product promotion, websites and social media
Learn about GMP validation – when is it required?
Understand how cleaning agents work and the best way to choose a cleaning agent
See the impact of proper documentation and record keeping
Understand why cleanliness is the key to success.
-
How to determine the risks for your organization – how to get started on the ERM journey.
How to weight risk to determine the key risks – not all risks are created equal.
How to develop a common risk language – ERM has a language that needs to be customized for your organization.
How to determine risk appetite – learn the steps for establishing your organization’s risk appetite.
Which is the appropriate risk framework for your organization – evaluate the different risk frameworks.
How to develop and prioritize a risk portfolio – develop an ERM heat map.
How to develop your management’s risk tolerance – a tactical consideration for your ERM journey.
Who is responsible for the risk – what are the roles of the Board of Directors, Executive Management, Chief Risk Officer and Internal Audit
How to decide to avoid, accept, reduce or control a risk – how do you respond to the risks identified.
The appropriate risk monitoring and reporting processes .
-
Learning Objectives:
Recognize the system of worldwide regulatory guidance applicable to biotech and biosimilar product CMC requirements
Understand why requirements for biotech products are so different from those of chemical products
Find exactly ‘where it is written’ for current and emerging CMC expectations for biotech/biosimilar products, and get copies of those regulatory documents
See how to implement a staged approach to establishing specifications for release and stability testing
Learn the current analytical technologies used for establishing biotech/biosimilar product characteristics and assessing comparability
Select the appropriate methods for release and stability testing
Design suitable qualification and validation exercises for method intended uses
Establish stage-appropriate ICH stability protocols
Learn the tiered approach for managing product reference standards
Recognize how much R&D data are exposed to regulatory scrutiny
-
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions.
Learning Objectives:
Understand how to comply with complicated Compliant Handling, MDR and Recall requirements.
Firms MDR reporting and FDA's handling of reports.
Company preparation in the event of a Recall, recall strategy, notification letter and communicating with the FDA.
Who will Benefit:
This course will benefit anyone in the medical device industry that handles functions involving product complaints, recalls, medical device reporting.
Regulatory Affairs
QA/QC
Project Managers
Regulatory Professional
Risk Managers
Note:
Use coupon code NB5SQH8N and get 10% off on registration.
-
The aim of the course is to provide:
An understanding of risk in all its facets
What the Basel Accords say about operational risk and its mitigation
An understanding of operational risk techniques for assessing, managing and mitigating operational risk
A link between ORM theory & practice
A clear "road-map" on how to implement an ORM structure in practice in a banking organization.
-
Learning Objectives:
Understand the kinds of business activity the antitrust laws absolutely prohibit, the kinds it permits if properly justified, and the kinds it does not apply to at all.
Learn the broad goals and objectives of the antitrust laws,
Possess a sensitivity to the specific business practices that can be considered anticompetitive,
Be able to communicate to others the reasons a particular practice could raise risk and should be brought to the attention of counsel or upper management,
Have a better ability to evaluate whether your company is the victim of an antitrust violation or unfair business practice,
Learn specific strategies for reducing the risks of communications with competitors,
Understand and reduce the risks of joining trade and professional organizations, of conducting surveys and participating in benchmarking studies,
Understand the significance to your business of antitrust decisions and enforcement actions reported in the press.
-
If you are looking for answer of these questions, you would certainly benefit by attending this seminar:
Are you a new or current small business owner who would like to ensure your business is organized to protect your assets and maximize your potential financial returns?
As a non-accountant, are you unsure how your books should be kept?
Do accounting concepts seem like a foreign language?
Do you want to save on taxes, and make sure you are in compliance with tax laws?
Do you want to understand what you should expect from the person that prepares your income tax returns and plans your tax strategies?